InvestorsHub Logo

J85

12/03/13 3:44 PM

#5979 RE: nbm16yankees #5978

I'm with you on these questions as the MSE kind of made us all a bit sceptical.

Therefore I believe the sales to be booked when sold, like with the MSE deal.

But in the end, we should have faith in Mr. James.
He didn't recontruct the entire company just to bring it down even sooner.
This company needed something new and Mr. James succeeded with new products. Hell, even the old products have record sales since he took over.

Now, these products must prove itself by bringing in revenue.

crookedneck

12/04/13 5:48 PM

#5992 RE: nbm16yankees #5978

This Intrinsix deal could be much bigger than we all thought!

Intrinsix is a brand new product that was just developed, so I doubt anyone has heard of it yet. It is not even listed as product yet on Podiatree's website: http://thepodiatreecompany.com/index.html , but I think it will be added soon.

From the PR it looks as though Podiatree will be handling the sales end to the 15,000 podiatrist offices nationwide, making this a great deal for NRTI. They produce it and Podiatree handles the sales calls to the 15,000 Podiatrist offices to have them stock it for their patients. Looks like a great partnership for NRTI. If only 1/2 of the Podiatrist offices carry and recommend the product and let's say 5 patients from each office buy it and keep reordering every month that would equate to 37,500 units monthly!

Now I have no idea what the cost will be and what NRTI will make off each bottle, but let's just say they make $1.00 a bottle for an example. That would equate to roughly $37,500 per month for them if Podiatree is as successful selling it, as in my example. Eventually I think the numbers could grow much larger than that, making it a nice money maker for the company. I think it could easily get to around 50,000 units per month with NRTI making $1.00 profit on each that would equate to $600,000.00 per year in the short term! Longer term I think this could be twice that, if not much more!

Starting to think this could be a much bigger deal than even I originally thought after taking a closer look at it. I don't think it is unreasonable to assume that 5 patients from 1/2 of the 15,000 Podiatrist offices would purchase it. Hell if I had that problem and my Podiatrist recommended a supplement to help it, I would buy it and take it daily.

I guess I really do need to speak to Mr. James on this to get a better understanding of how this will work. If it could result in revenues in my example, it will continue to grow into something much larger down the road. I'm Liking It!

Below is The Podiatree Company philosophy statement and the PR from yesterday. Cheers!


Our Philosophy
At The Podiatree Company, it is our mission to improve foot health. So much so, we named our business after the profession that embodies foot care and to acknowledge the invaluable contributions podiatrists have made to patient care and overall quality of life.

We have a special focus on the needs of patients who suffer from diabetes as their care takes an enduring commitment. As part of our commitment, at the end of every calendar year, a portion of annual sales will be donated to the Diabetes Research Institute, Juvenile Diabetes Research Foundation and other not-for-profit organizations that support diabetes research.

The traditional values of trust, honesty and respect are the cornerstones of our company. We believe they are fundamental to build the enduring relationships we desire. We believe in taking the high road and welcome the challenge of conducting our business the right way.

We are committed to serving our customers. This is Our Guarantee; we hope it serves as an example of how our actions speak for themselves.

We are committed to provide safe, premium foot care products that exceed your expectations. Our product offering is formulated specifically for foot health. We use the finest ingredients backed by science whether traditional medicine or alternative therapy. All products are manufactured at facilities with stringent quality control to ensure safety, stability, and efficacy.

We are passionate about continuous improvement. With our management team's 35 years of foot care product experience, we consider ourselves eager disciples of the ongoing advancements in this field. We are never satisfied and endeavor to continue to improve both our service and our quality product offerings.


Inergetics Announces Launch of Intrinsix, a Pharmacist-Formulated Supplement to Support Healthy Nerve Function and Foot Health

Enriched Supplement Co-Developed with The Podiatree Company for Diabetic Patients who Suffer from Nerve-Related Symptoms

NEWARK, N.J., Dec. 3, 2013 /PRNewswire/ -- Inergetics, Inc. (NRTI), a leading developer of nutritional supplements, and The Podiatree Company, a leader in podiatry pharmaceuticals, today launched Intrinsix -- the only podiatry-exclusive nerve health support supplement enriched with calcium and vitamin D.

Developed alongside pharmacist, Robert Graci, R.Ph., Inergetics has created a unique formula to support healthy nerve function and specifically help diabetic patients who experience nerve-related symptoms in their extremities, which include tingling, pain, burning, and loss of sensation.

"With approximately 15,000 podiatrists practicing in the U.S., we are taking a direct sales approach to help them support the ever-increasing proportion of the population suffering with diabetes," said Inergetics CEO Mike James. "Intrinsix is a great addition to the Inergetics family and we look forward to continuing our work with The Podiatree Company to advance foot care for the benefit of patients."

"As a company dedicated to the podiatry specialty market, we take pride in being able to provide our physician partners with unique and efficacious specialty products to meet their patients' needs," added Robert Graci, R.Ph.

Intrinsix contains a unique pharmacist-formulated blend of alpha lipoic acid, benfotiamine, calcium, and vitamins B6, B12 and D. The formula is safe for patients with strict dietary restrictions, including vegetarians and those with sugar-free, sodium-free and starch-free diets.

Intrinsix has been distributed for sale to local podiatrists across the U.S. and will be available immediately to their patients.